ARE TUMORAL MARKERS PREDICTIVE FACTORS FOR MOLECULAR SUBTYPES IN BREAST CANCER? | Zendy

V.C. Munteanu | Zendy; Georgiana Radu | Zendy; Monica Mihaela Cîrstoiu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ARE TUMORAL MARKERS PREDICTIVE FACTORS FOR MOLECULAR SUBTYPES IN BREAST CANCER?

Author(s) -

V.C. Munteanu,

Georgiana Radu,

Monica Mihaela Cîrstoiu

Publication year - 2019

Publication title -

journal of surgical sciences

Language(s) - English

Resource type - Journals

eISSN - 2457-5364

pISSN - 2360-3038

DOI - 10.33695/jss.v5i4.249

Subject(s) - breast cancer , oncology , medicine , molecular pathology , cancer , neoplasm , immunohistochemistry , pathology , gene , biology , biochemistry

Breast cancer kills more women annually than any other type of neoplasm. Even though he has shown a particular interest in the medical body since ancient times, the very heterogeneous nature of the tumors and their versatility have made it difficult to find a diagnostic and therapeutic consensus that fully characterizes this pathology and describes its evolution. Immunohistochemical methods manage to outline a gene-molecular profile depending on the biomarkers expressed by each tumor. Correlations between clinical aspects and molecular characteristics of tumors are of particular importance in the management of such a case. The study examined the impact of breast cancer molecular subtypes on therapeutic management for a group of 438 patients treated on the Oncology Department of the Bucharest University Emergency Hospital during 2007-2017.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research